Cell & Bioscience · 2014 · 16 citations · 29 references
MedicineMolecular BiologyOncologyGene ExpressionInflammationTranscriptional RegulationBiomarkers Of Liver InjuryCancer Cell SignalingHepatic PathophysiologyHepatocellular CarcinomaInflammatory SignalingLiver CancerHepatic Inflammatory InjuryHepatocellular Carcinoma PathogenesisInflammation In Liver InjuryLiver Inflammation SignalingPromoter-promoter Interactions
BACKGROUND: Golgi protein-73 (GP73) is a Golgi transmembrane glycoprotein elevated in numerous liver diseases. Clinically, GP73 is strongly elevated in the serum of HCC patients and is thus regarded as a novel potential biomarker for HCC. However, the mechanism leading to GP73 dysregulation in liver diseases remains unknown. RESULTS: This study determined that epithelium-specific ETS (ESE)-1, an epithelium-specific transcription factor, and GP73 expressions were induced by IL-1β stimulation in vitro, and both were triggered during liver inflammation in vivo. In hepatocellular carcinoma cells, the overexpression of ESE-1 induced GP73 expression, whereas its knock-down did the opposite. Mechanistically, ESE-1 activated GP73 expression by directly binding to its promoter. CONCLUSIONS: Our findings supported a novel paradigm for ESE-1 as a transcriptional mediator of GP73. This study provided a possible mechanism for GP73 upregulation in liver diseases.
29
Timothy M. Block, Mary Ann Comunale, Melissa Lowman et al. · Proceedings of the National Academy of Sciences · 2005 · 370 citations · Full text
GP73, a novel Golgi-localized protein upregulated by viral infection
Raleigh D. Kladney, Gary A. Bulla, Linsheng Guo et al. · Gene · 2000 · 281 citations · Full text
Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma
Yilei Mao, Huayu Yang, Haifeng C. Xu et al. · Gut · 2010 · 264 citations
Medicine, Biochemistry, Oncology +17